Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market
Holding SYRE?
Track your performance easily

Spyre Therapeutics (SYRE) Ownership - Who Owns Spyre Therapeutics?

414 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 05, 2024
xxxxxxxxxxxxx
$522018

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$3408950
Jun 30, 2024
xxxxxxxxxxxxx
$6174102
Jun 30, 2024
xxxxxxxxxxxxx
$6888312
Jun 30, 2024
xxxxxxxxxxxxx
$15657660

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,018,101Institution7.89%116,364,205
3,031,018Institution5.95%87,778,281
1,837,276Institution3.61%53,207,513
1,658,509Institution3.26%48,030,421
1,586,386Institution3.12%45,941,739
1,309,824Institution2.57%37,932,503
1,068,825Institution2.10%30,953,172
910,295Institution1.79%26,362,143
809,168Institution1.59%23,433,505
753,063Institution1.48%21,808,704

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,658,509Institution3.26%48,030,421
1,586,386Institution3.12%45,941,739
1,068,825Institution2.10%30,953,172
910,295Institution1.79%26,362,143
809,168Institution1.59%23,433,505
365,165Institution0.72%10,575,178
255,100Institution0.50%7,387,696
207,880Institution0.41%6,020,205
186,100Institution0.37%5,389,456
143,704Institution0.28%4,161,668

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,099,500Institution2.16%30,236,250
911,717Institution1.79%26,768,011
706,863Institution1.39%20,103,184
489,721Institution0.96%13,467,328
297,094Institution0.58%8,722,680
136,482Institution0.27%3,753,255
61,308Institution0.12%1,685,970
37,519Institution0.07%1,101,558
30,617Institution0.06%898,915
29,337Institution0.06%861,334

FAQ

Who Owns Spyre Therapeutics (SYRE)?
Currently, no data Available
What percentage of Spyre Therapeutics (SYRE) stock is held by institutional investors?
Currently, no data Available
What percentage of Spyre Therapeutics (SYRE) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Spyre Therapeutics (SYRE)?
Peter Harwin owns the most shares of Spyre Therapeutics (SYRE).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis